Abstract
Histoplasma infections in Europe are rare, and acute disseminated histoplasmosis has been observed only in immunocompromised persons. An unusual case of autochthonous disseminated histoplasmosis in a 22-year-old Spanish man who had been treated with azathioprine and prednisone for 4 weeks before admission is reported. The development of an acute form of the disease may represent an endogenous reactivation of a latent infection as a complication of immunosuppression resulting from the use of these drugs. This case illustrates the potential risk of this opportunistic fungal infection in patients receiving azathioprine therapy, an association that has been rarely described before.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goodwin RA, Shapiro JL, Thermann GH, Thermann SS, Des Prez RM: Disseminated histoplasmosis: clinical and pathological correlations. Medicine (1980) 59:1–33
Daves SF. Histoplasmosis: update 1989. Seminars in Respiratory Infections (1989) 2:93–104
Suthanthiran M, Morris RE, Strom TB: Immunosuppressants: cellular and molecular mechanisms of action. American Journal of Kidney Diseases (1996) 28:159–172
Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K: Respiratory complications of cardiac transplantation. American Journal of Medical Sciences (1988) 296:1–10
Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S: Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft versus host disease, Blood (1987) 72:546–554
Laufer G, Kaczkovics A, Wollenek G, Buxbaum P, Graninger W, Holzinger C: Infectious complications in heart transplant recipients with combined low dose cyclosporine, azathioprine, and prednisolone (triple drug) immunosuppression. Transplantation Proceedings (1989) 21:2508–2511
Sassuna JH, Machado RD, Sampaio JC, Leite LL, Villela LH, Ruzany F, Souza ER: Active cytomegalovirus infection in hemodialysis receiving donorspecific blood transfusions under azathioprine coverage. Transplantation (1993) 56:1552–1554
Davies SF, Sarosi GA, Peterson PK, Khan M, Howard RJ, Simmons RL: Disseminated histoplasmosis in renal transplant recipients. American Journal of Surgery (1979) 137:686–691
Witty LA, Steiner F, Curfmann M, Webb D, Wheat LJ: Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis. Archives of Dermatology (1992) 128:91–93
Lemense GP, Sahn SA: Opportunistic infection during treatment with low dose methotrexate. American Journal of Respiratory and Critical Care Medicine (1994) 150:258–260
Manfredi R, Mazzoni A, Nanneti A, Chiodo F. Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel, and immigration. European Journal of Epidemiology (1994) 10:675–681
De Closets F, Rossaza C, Bella L, Marduel M: A propos de lesions ophtalmologiques de type histoplasmique observées a tours. Bulletin de la Societé FranÇaise de Mycologie Médicale (1990) 19:91–94
Gandola L, Confalonieri M, Aiolfi S, Scartabellati A, Patrini G, Ghio L, Mauri F: Histoplasmosis in an HIV-negative Italian man with mycosis fungoides. Panminerva Medica (1992) 34:93–95
Harten P, Baron Y, Euler HH: Liposomal amphotericin B therapy in disseminated histoplasmosis. Archives of Internal Medicine (1995) 155:1556
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poveda, F., García-Alegría, J., de las Nieves, M.A. et al. Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area. Eur. J. Clin. Microbiol. Infect. Dis. 17, 357–359 (1998). https://doi.org/10.1007/BF01709461
Issue Date:
DOI: https://doi.org/10.1007/BF01709461